Bruce Psaty
|
Professor, General Internal Medicine University of Washington |
Research Interests
Cardiovascular epidemiology; pharmacoepidemiology epidemiologic methods; patient-physician interaction; pharmacogenetics; genomics; drugs safety
Related Links
Epidemiology Biography Page
Health Services Biography Page
SciVal Experts Page
Education
MD Indiana University, 1981
PhD English, Indiana University, 1979
MPH Epidemiology, University of Washington, 1986
MA English, Indiana University, 1975
AB English, Princeton University, 1972
In the News
- Screening Children for Cholesterol
New York Times, 02/15/2012 - Land of the overmedicated?
Buffalo News, 01/04/2011 - Overmedication: Are Americans Taking Too Many Drugs?
US News & World Report, 10/07/2010 - Major Heart Disease Genes Prove Elusive
Science, 06/16/2010 - Remove Diabetes Drug Avandia From Market: FDA Reports
US News & World Report, 02/23/2010 - Merck Paying More Than 3,100 Vioxx Death Claims
Bloomberg.com, 09/25/2009 - Framingham Heart Study follows the beat in new directions
Los Angeles Times, 05/19/2009 - Medical researchers face conflicts of interest
Reuters, 04/10/2009 - Doctors debate Vytorin cancer risk at heart meeting
Reuters, 11/13/2008 - Health care in an Obama world: what we know so far
EmaxHealth, 11/06/2008 - Life After Andy: Searching For FDA Leadership
Pharmalot, 11/06/2008 - Researchers: Merck Vioxx study was for marketing
WashingtonPost.com, 08/19/2008 - Dark Cloud Over Amylin
Forbes.com, 08/19/2008 - Trial Intensifies Concerns About Safety of Vytorin
The New York Times, 07/22/2008 - FDA to Expand Scrutiny of Risks From Drugs After They’re Approved for Sale
The New York Times, 05/23/2008